Literature DB >> 15157667

Antigen receptor-mediated signaling pathways in transitional immature B cells.

Dorottya Kövesdi1, Katalin Pászty, Agnes Enyedi, Endre Kiss, János Matkó, Katalin Ludányi, Eva Rajnavölgyi, Gabriella Sármay.   

Abstract

Engagement of antigen receptors on immature B cells induces apoptosis, while at the mature stage, it stimulates cell activation and proliferation. The difference in B cell receptor (BCR)-mediated signaling pathways regulating death or survival of B cells is not fully understood. We aimed to characterize the pathway leading to BCR-driven apoptosis. Transitional immature B cells were obtained from the spleen of sublethally irradiated and auto-reconstituted mice. We have detected a short-lived BCR-driven activation of mitogen-activated protein kinases (ERK1/2 and p38 MAPK) and Akt/PKB in transitional immature B cells that correlated with the lack of c-Fos expression, reduced phosphorylation of Akt substrates and a susceptibility for apoptosis. Simultaneous signaling through BCR and CD40 protected immature B cells from apoptosis, however, without inducing Bcl-2 expression. The BCR-induced apoptosis of immature B cells is a result of the collapse of mitochondrial membrane potential and the subsequent activation of caspase-3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157667     DOI: 10.1016/j.cellsig.2004.01.005

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells.

Authors:  Sarah F Andrews; Xuezhi Dai; Byoung Y Ryu; Tod Gulick; Bindu Ramachandran; David J Rawlings
Journal:  Eur J Immunol       Date:  2012-05       Impact factor: 5.532

2.  Anti-nuclear antibody production and autoimmunity in transgenic mice that overexpress the transcription factor Bright.

Authors:  Malini Shankar; Jamee C Nixon; Shannon Maier; Jennifer Workman; A Darise Farris; Carol F Webb
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

3.  Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Authors:  Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  Insulin-like growth factor-2 enhances functions of antigen (Ag)-specific regulatory B cells.

Authors:  Xiao-Rui Geng; Gui Yang; Meng Li; Jiang-Ping Song; Zhi-Qiang Liu; Shuqi Qiu; Zhigang Liu; Ping-Chang Yang
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

5.  Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7.

Authors:  Angela Malaspina; Susan Moir; Jason Ho; Wei Wang; Melissa L Howell; Marie A O'Shea; Gregg A Roby; Catherine A Rehm; Joann M Mican; Tae-Wook Chun; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

6.  Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice.

Authors:  Paul A Blair; Karina A Chavez-Rueda; Jamie G Evans; Mark J Shlomchik; Ayad Eddaoudi; David A Isenberg; Michael R Ehrenstein; Claudia Mauri
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

7.  Targeting antigens to CD180 rapidly induces antigen-specific IgG, affinity maturation, and immunological memory.

Authors:  Jay W Chaplin; Craig P Chappell; Edward A Clark
Journal:  J Exp Med       Date:  2013-09-09       Impact factor: 14.307

8.  Protection of mice deficient in mature B cells from West Nile virus infection by passive and active immunization.

Authors:  Daniela Giordano; Kevin E Draves; Lucy B Young; Kelsey Roe; Marianne A Bryan; Christiane Dresch; Justin M Richner; Michael S Diamond; Michael Gale; Edward A Clark
Journal:  PLoS Pathog       Date:  2017-11-27       Impact factor: 6.823

Review 9.  Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases.

Authors:  Zhou Ran; Luo Yue-Bei; Zeng Qiu-Ming; Yang Huan
Journal:  Front Immunol       Date:  2020-08-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.